Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness

• Главные авторы: N. Yu. Mironov (Автор), V. V. Vlodzyanovskiy (Автор), Yu. A. Yuricheva (Автор), S. F. Sokolov (Автор), S. P. Golitsyn (Автор), L. V. Rosenstraukh (Автор), E. I. Chazov (Автор)
• Формат: ‌
• Опубликовано: Столичная издательская компания, 2018-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Aim. We aimed to compare effectiveness of new  class III antiarrhythmic drug  Refralon with direct current  cardioversion (DCC) in patients with persistent atrial fibrillation (AF).Material and methods. 60  patients with persistent AF were  randomized to groups  of DCC (n=30) and  pharmacologic conv...